Mallinckrodt Pharmaceuticals to Hold Investor Briefing in New York

Published: Nov 08, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DUBLIN--(BUSINESS WIRE)--Mallinckrodt (NYSE:MNK), a global specialty pharmaceutical and global medical imaging company, will hold an investor briefing on November 14, 2013. The meeting will be held at the Grand Hyatt at 109 East 42nd Street at Grand Central Terminal New York, NY from 8:30am to 9am Eastern Standard Time. Mark Trudeau, President and CEO of Mallinckrodt, along with members of Mallinckrodt’s senior management team, will present.

Help employers find you! Check out all the jobs and post your resume.

Back to news